Back to Search
Start Over
Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.
- Source :
- PharmacoEconomics; May2023, Vol. 41 Issue 5, p605-605, 1p
- Publication Year :
- 2023
-
Abstract
- B Correction to: PharmacoEconomics 40, 699-714 (2022) b https://doi.org/10.1007/s40273-022-01168-0 The following sentence was erroneously omitted from the Acknowledgements section of the article: The authors thank Alvin Ng, Alex Porteous, Faye Saville, Flo Anderson and Jennifer Page, employees of Costello Medical, Cambridge, UK, for deriving the US utility values employed in the analysis. The original article can be found online at https://doi.org/10.1007/s40273-022-01168-0. [Extracted from the article]
- Subjects :
- COVID-19 treatment
MOLNUPIRAVIR
OUTPATIENT medical care
ADULTS
COST effectiveness
Subjects
Details
- Language :
- English
- ISSN :
- 11707690
- Volume :
- 41
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- PharmacoEconomics
- Publication Type :
- Academic Journal
- Accession number :
- 162992353
- Full Text :
- https://doi.org/10.1007/s40273-023-01263-w